Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Attention Deficit Hyperactivity Disorder
100%
Stimulant Medication
100%
ADHD Medication
100%
Long-term Efficacy
75%
Adverse Effects
50%
European Medicines Agency
50%
Randomized Controlled Trial
25%
Placebo-controlled
25%
Methylphenidate
25%
Prodrug
25%
Short-term Study
25%
Atomoxetine
25%
Guanfacine
25%
Clonidine
25%
Randomized Withdrawal
25%
Short-term Efficacy
25%
Amphetamine Derivatives
25%
Withdrawal Design
25%
Effectiveness Study
25%
Safety Signal
25%
Medicine and Dentistry
Attention Deficit Disorder
100%
Analeptic
100%
Randomized Controlled Trial
60%
Adverse Effect
40%
Placebo
20%
Atomoxetine
20%
Prodrug
20%
Methylphenidate
20%
Effectiveness Study
20%
Clonidine
20%
Amphetamine Derivative
20%
Guanfacine
20%
Neuroscience
Attention Deficit Hyperactivity Disorder
100%
Analeptic
100%
Adverse Effect
40%
Randomized Controlled Trial
20%
Placebo
20%
Methylphenidate
20%
Atomoxetine
20%
Amphetamine
20%
Prodrug
20%
Guanfacine
20%
Clonidine
20%
Pharmacology, Toxicology and Pharmaceutical Science
Attention Deficit Disorder
100%
Randomized Controlled Trial
60%
Adverse Effect
40%
Placebo
20%
Methylphenidate
20%
Prodrug
20%
Effectiveness Study
20%
Atomoxetine
20%
Guanfacine
20%
Clonidine
20%
Amphetamine Derivative
20%
Psychology
Attention Deficit Hyperactivity Disorder
100%
Adverse Effect
40%
Study Design
20%
Methylphenidate
20%
Amphetamine
20%
Social Sciences
Attention Deficit Hyperactivity Disorder
100%
Randomized Controlled Trial
60%